Corrigendum to “Intestinal Preconditioning Ameliorates Ischemia-Reperfusion Induced Acute Lung Injury in Rats: An Experimental Study” [Journal of Surgical Research 160(2) (2010) 294–301](S002248040801576X)(10.1016/j.jss.2008.12.017);Intestinal Preconditioning Ameliorates Ischemia-Reperfusion Induced Acute Lung Injury in Rats: An Experimental Study

Journal of Surgical Research

Volumn 160, Issue 2, 2010, Pages 294-301

  Avgerinos, Efthimios D ^a   Kostopanagiotou, Georgia ^a   Costopanagiotou, Constantinos ^a   Kopanakis, Nikolaos ^a   Andreadou, Ioanna ^b   Lekka, Marilena ^c   Nakos, George ^c   Smyrniotis, Vasilios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

acute respiratory distress syndrome; intestinal ischemia reperfusion; ischemic preconditioning; platelet activating factor acetylohydrolase

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; MALONALDEHYDE; PHOSPHOLIPASE A2 INHIBITOR;

ACUTE LUNG INJURY; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; BIOCHEMISTRY; BLOOD GAS ANALYSIS; BLOOD SAMPLING; CONDITIONING; CONTROLLED STUDY; CYTOLOGY; EXPERIMENTAL STUDY; INTESTINAL PRECONDITIONING; INTESTINE ISCHEMIA; LUNG LAVAGE; MALE; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANK SUM TEST; RAT; REPERFUSION INJURY; WISTAR RAT;

EID: 77950915956     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2017.11.042     Document Type: Erratum

References (41)

1. Harward T.R., Brooks D.L., Flynn T.C., et al. Multiple organ dysfunction after mesenteric artery revascularization. J Vasc Surg 18 (1993) 459
2. Turnage R.H., Guice K.S., and Oldham K.T. Pulmonary microvascular injury following intestinal reperfusion. New Horiz 2 (1994) 463
3. Simpson R., Alon R., Kobzi L., et al. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg 218 (1993) 444
4. Collard C.D., and Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 94 (2001) 1133
5. Koike K., Moore F.A., Moore E.E., et al. Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res 52 (1992) 656
6. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 49 (1999) 91
7. Xiao F., Eppihimer M.J., Willis B.H., et al. Complement-mediated lung injury and neutrophil retention after intestinal ischemia-reperfusion. J Appl Physiol 82 (1997) 1459
8. Anderson B.O., Moore E.E., and Banerjee A. Phospholipase A2 regulates critical inflammatory mediators of multiple organ failure. J Surg Res 56 (1994) 199
9. Capper E.A., and Marshall L.A. Mammalian phospholipases A(2): Mediators of inflammation, proliferation and apoptosis. Prog Lipid Res 40 (2001) 167
10. 2. J Surg Res 147 108 (2008) 2007 (Epub ahead of print)
11. Tarbet E.B., Stafforini D.M., Elstad M.R., et al. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. J Biol Chem 266 (1991) 16667
12. Balsinde J., Balboa M.A., Insel P.A., et al. Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol 39 (1999) 175
13. Mallick I.H., Yang W., Winslet M.C., et al. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 49 (2004) 1359
14. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124
15. Moore-Olufemi S.D., Kozar R.A., Moore F.A., et al. Ischemic preconditioning protects against gut dysfunction and mucosal injury after ischemia/reperfusion injury. Shock 23 (2005) 258
16. Tamion F., Richard V., Lacoume Y., et al. Intestinal preconditioning prevents systemic inflammatory response in hemorrhagic shock. Role of HO-1. Am J Physiol Gastrointest Liver Physiol 283 (2002) G408
17. Lowry O.H., Rosebrough N.I., Farr A.L., et al. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265
18. Kitsiouli E.I., Nakos G., and Lekka M.E. Differential determination of phospholipase A(2) and PAF-acetylhydrolase in biological fluids using fluorescent substrates. J Lipid Res 40 (1999) 2346
19. Nakos G., Kitsiouli E.I., Tsangaris I., et al. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med 24 (1998) 296
20. Andreadou I., Iliodromitis E.K., Tsovolas K., et al. Acute administration of vitamin E triggers preconditioning via KATP channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radic Biol Med 41 (2006) 1092
21. Chiu C.J., McArdle A.H., Brown R., et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Sur 101 (1970) 478
22. Millar C.G., Baxter G.F., and Thiemermann C. Protection of the myocardium by ischemic preconditioning: Mechanisms and therapeutic implications. Pharmacol Ther 69 (2006) 143
23. Hawaleshka A., and Jacobsohn E. Ischemic preconditioning: Mechanisms and potential clinical applications. Can J Anaesth 45 (1998) 670
24. Sola A., Hotter G., Prats N., et al. Modification of oxidative stress in response to intestinal preconditioning. Transplantation 69 (2000) 767
25. Guo Y., Jones W.K., Xuan Y.T., et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 96 (1999) 11507
26. Yamashita N., Nishida M., Hoshida S., et al. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest 94 (1994) 2193
27. De Oca J., Hotter G., Sola A., et al. Role of nitric oxide in preconditioning for intestinal transplantation. Transplant Proc 31 (1999) 2573
28. Sola A., Rosello-Catafau J., Alfaro V., et al. Modification of glyceraldehyde-3- phosphate dehydrogenase in response to nitric oxide in intestinal preconditioning. Transplantation 67 (1999) 1446
29. Poussios D., Andreadou I., Papalois A., et al. Protective effect of a novel antioxidant non-steroidal anti-inflammatory agent (compound IA) on intestinal viability after acute mesenteric ischemia and reperfusion. Eur J Pharmacol 465 (2003) 275
30. Grissom C.K., Orme Jr. J.F., Richer L.D., et al. Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome. Crit Care Med 31 (2003) 770
31. Kostopanagiotou G., Routsi C., Smyrniotis V., et al. Alterations in bronchoalveolar lavage fluid during ischemia-induced acute hepatic failure in the pig. Hepatology 37 (2003) 1130
32. Nakos G., Kitsiouli E., Hatzidaki E., et al. Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 33 (2005) 772
33. Bellido-Reyes Y.A., Akamatsu H., Kojima K., et al. Cytosolic phospholipase A2 inhibition attenuates ischemia-reperfusion injury in an isolated rat lung model. Transplantation 81 (2006) 1700
34. Furue S., Mikawa K., Nishina K., et al. Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury: Correlation with lung surfactant protection. Crit Care Med 29 (2001) 719
35. Nagase T., Uozumi N., Aoki-Nagase T., et al. A potent inhibitor of cytosolic phospholipase A2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 284 (2003) L720
36. Reyes Y.A., Shimoyama T., Akamatsu H., et al. MCI-186 (edavarone), a free radical scavenger, attenuates ischemia-reperfusion injury and activation of phospholipase A2 in an isolated rat lung model after 18h of cold preservation. Eur J Cardiothorac Surg 29 (2006) 304
37. Pawliczak R., Huang X.L., Nanavaty U.B., et al. Oxidative stress induces arachidonate release from human lung cells through the epithelial growth factor receptor pathway. Am J Respir Cell Mol Biol 27 (2002) 722
38. Matsuzawa A., Hattori K., Aoki J., et al. Protection against oxidative stress-induced cell death by intracellular platelet activating factor-acetyl hydrolase II. J Biol Chem 272 (1997) 32315
39. Kim J.D., Baker C.J., Roberts R.F., et al. Platelet activating factor acetyl hydrolase decreases lung reperfusion injury. Ann Thorac Surg 70 (2000) 423
40. Nakos G., Pneumatikos J., Tsangaris I., et al. Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema. Am J Respir Crit Care Med 155 (1997) 945
41. Claudia P., Alloatti G., Cappello S., et al. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. Am J Physiol Heart Circ Physiol 288 (2005) H2512